Drugs that target dynamic microtubules: a new molecular perspective.
Reads0
Chats0
TLDR
The effects of microtubule‐binding chemotherapeutic agents are reviewed from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of micro Tubule assembly or disassembly.Abstract:
Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle apparatus. As such, there is a wide variety of compounds currently in clinical use and in development that act as antimitotic agents by altering microtubule dynamics. Although these diverse molecules are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research. In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of microtubule assembly or disassembly. These “biological vectors” can thus be used as a spatiotemporal context to describe molecular mechanisms by which microtubule-targeting drugs work.read more
Citations
More filters
Journal ArticleDOI
Carbon nanotubes for delivery of small molecule drugs
Bin Sheng Wong,Sia Lee Yoong,Anna Jagusiak,Tomasz Panczyk,Han Kiat Ho,Wee Han Ang,Giorgia Pastorin +6 more
TL;DR: The delivery of small molecule drugs is expounded, with special attention paid to the current progress of in vitro and in vivo research involving CNT-based DDSs, before finally concluding with some consideration on inevitable complications that hamper successful disease intervention with CNTs.
Journal ArticleDOI
Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death
Malgorzata Borowiak,Malgorzata Borowiak,Wallis Nahaboo,Martin Reynders,Katharina Nekolla,Pierre Jalinot,Jens Hasserodt,Markus Rehberg,Marie Delattre,Stefan Zahler,Angelika M. Vollmar,Dirk Trauner,Oliver Thorn-Seshold,Oliver Thorn-Seshold +13 more
TL;DR: The photostatins are introduced, inhibitors that can be switched on and off in vivo by visible light, to optically control microtubule dynamics and are promising as a new class of precision chemotherapeutics whose toxicity may be spatiotemporally constrained using light.
Journal ArticleDOI
Plant-derived Immunomodulators: An Insight on Their Preclinical Evaluation and Clinical Trials
TL;DR: The present review will give an overview of widely investigated plant-derived compounds which have exhibited potent effects on cellular and humoral immune functions in pre-clinical investigations and will highlight their clinical potential.
Journal ArticleDOI
Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites
TL;DR: The identified plants and compounds offer a chance to develop new drugs against parasitic diseases and need to be tested in more detail, especially in animal models and if successful, in clinical trials.
Journal ArticleDOI
Plant-Derived Anti-Inflammatory Compounds: Hopes and Disappointments regarding the Translation of Preclinical Knowledge into Clinical Progress
Robert Fürst,Ilse Zündorf +1 more
TL;DR: This minireview will summarize the current situation of 6 very prominent plant-derived anti-inflammatory compounds: curcumin, colchicine, resveratrol, capsaicin, epigallocatechin-3-gallate (EGCG), and quercetin, and sum up the planned trials in order to provide insights into the inflammatory disorders that are hypothesized to be beneficially influenced by the compound.
References
More filters
Journal ArticleDOI
Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and t-cell lymphoma
TL;DR: 9-nitro-nos has great potential to be a novel therapeutic agent for ovarian and T-cell lymphoma cancers, even those that have become drug-resistant to currently available chemotherapeutic drugs.
Journal ArticleDOI
Microtubule-macrotubule transitions: intermediates after exposure to the mitotic inhibitor vinblastine.
TL;DR: Vinblastine treatment of microtubule protein or intact microtubules assembled in vitro produced bifilar rings andbifilar helices, which are suggested to consist of tightly coiled helices formed by longitudinal compacting of loosely coiled protofilament pair intermediates.
Journal ArticleDOI
Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Yihua Wang,Xiaobo Zhou,Xiaobo Zhou,Hongxia Zhu,Shuang Liu,Cuiqi Zhou,Guo Zhang,Liyan Xue,Ning Lu,Lanping Quan,Jinfeng Bai,Qimin Zhan,Ningzhi Xu +12 more
TL;DR: The novel hypothesis that EB1 overexpression may play a role in the development of ESCC by affecting APC function and activating the β-catenin/TCF pathway is supported.
Journal ArticleDOI
Role of B-ring of colchicine in its binding to tubulin.
TL;DR: It is concluded that although the presence of the B-ring of colchicine does not appear to be an essential prerequisite for the drug-tubulin interaction, theB-ring substituents play an important role in determining the binding properties of col chicine to tubulin.
Journal ArticleDOI
Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.
TL;DR: Results confirm that peloruside A, when added in combination with other microtubule stabilizing agents, acts synergistically to enhance the antimitotic action of the drugs, but also highlight the complexity of drug interactions in intact cells.
Related Papers (5)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet,Mary Ann Jordan +1 more